CNCE: Concert Pharmaceuticals, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Concert Pharmaceuticals, Inc.

NASDAQ:CNCE

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$8.37
Loss Chance
58.0%
1.64JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.28
$30.52
43.28%
Dynavax Technologies Corporation
NASDAQ:DVAX
4.69
$15.50
49.83%
Eagle Pharmaceuticals
NASDAQ:EGRX
3.69
$3.19
93.14%
Genmab A/S
NASDAQ:GMAB
6.50
$27.89
10.87%
Genfit S.A.
NASDAQ:GNFT
1.61
$4.80
100.00%
Jitta Factors
Growth Opportunity (48)
Recent Business Performance (64)
Financial Strength (35)
Return to Shareholders (4)
Competitive Advantage (35)
Jitta Signs
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2021
Operating MarginInconsistent
Recent Business PerformanceEarning decline 1.58% in the last year
New Share IssuedMore than 50% in 5 years
Key Stats
Jitta Score
Jitta Line
1.64
100.00%
2.23
183.90%
3.07
154.49%
Biotechnology
6.28
43.28%
4.69
49.83%
3.69
93.14%
COMPANY DESCRIPTION
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company’s lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of March 6, 2023, Concert Pharmaceuticals, Inc. operates as a subsidiary of Sun Pharmaceutical Industries Limited.
www.concertpharma.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.